Quarterly Results

VISTA PHARMACEUTICALS LTD.

NSE : NABSE : 524711ISIN CODE : INE427C01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE11.20-0.09 (-0.8 %)
PREV CLOSE ( ) 11.29
OPEN PRICE ( ) 11.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5027
TODAY'S LOW / HIGH ( )10.80 11.40
52 WK LOW / HIGH ( ) 9.116.5
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Audited / UnAudited
Audited
UnAudited
UnAudited
UnAudited
Net Sales
32.3
25.55
24.95
17.95
Total Expenditure
41.41
40.72
33.19
25.72
PBIDT (Excl OI)
-9.11
-15.17
-8.24
-7.77
Other Income
2.41
1.22
0.07
0.71
Operating Profit
-6.7
-13.95
-8.17
-7.06
Interest
2.06
2.23
2.53
2.82
Exceptional Items
NA
NA
NA
NA
PBDT
-8.76
-16.18
-10.7
-9.88
Depreciation
1.85
1.87
1.83
1.83
Profit Before Tax
-10.61
-18.05
-12.53
-11.71
Tax
4.33
-4.82
-2.78
-3.14
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-14.94
-13.23
-9.75
-8.57
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-14.94
-13.23
-9.75
-8.57
Equity Capital
123.1
123.1
123.1
123.1
Face Value (IN RS)
2
2
2
2
Reserves
Calculated EPS
-0.24
-0.21
-0.15
-0.13
Calculated EPS (Annualised)
-0.97
-0.85
-0.63
-0.55
No of Public Share Holdings
48511720
48511720
48511720
48511720
% of Public Share Holdings
78.81
78.81
78.81
78.81
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-28.20
-59.37
-33.02
-43.28
PBIDTM%
-20.74
-54.59
-32.74
-39.33
PBDTM%
-27.12
-63.32
-42.88
-55.04
PBTM%
-32.84
-70.64
-50.22
-65.23
PATM%
-46.25
-51.78
-39.07
-47.74
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.